跳至主要内容
临床试验/NCT03183037
NCT03183037已完成不适用

Acupuncture for Persistent Chemotherapy-induced Peripheral Neuropathy Symptoms in Solid Tumor Survivors: A Pilot Study

Memorial Sloan Kettering Cancer Center3 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2017年6月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
3
主要终点
change in the proportion of patients with a CIPN severity

研究概览

简要总结

The purpose of this study is to compare the effects of real acupuncture with placebo acupuncture or usual care on symptoms of nerve damage from chemotherapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • English-speaking
  • Age ≥ 18 years old
  • Solid tumor survivors with no evidence of disease
  • Moderate to severe CIPN, defined by symptoms such as numbness, tingling, or pain ratings of 4 or greater on a 0-10 numeric rating scale (NRS)
  • Have completed neurotoxic chemotherapy at least 3 months prior to enrollment
  • If taking anti-neuropathy medications, they are on a stable regimen (no change in 3 months)

排除标准

  • Patients with a pacemaker
  • Prior acupuncture treatment within 5 years of enrollment

结局指标

主要结局

change in the proportion of patients with a CIPN severity

时间窗: up to 12 weeks

according to the NCI-CTC 4.0

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验